94 related articles for article (PubMed ID: 19052118)
1. Prothrombin time for detection of contaminated heparins.
Alban S; Lühn S
N Engl J Med; 2008 Dec; 359(25):2732-4. PubMed ID: 19052118
[No Abstract] [Full Text] [Related]
2. Contaminants in heparins: are all facts known?
Fareed J; Hoppensteadt DA; Ramacciotti E; Hull RD
Clin Appl Thromb Hemost; 2010 Jun; 16(3):242-3. PubMed ID: 20547552
[No Abstract] [Full Text] [Related]
3. Contaminated heparin.
Greinacher A; Warkentin TE
N Engl J Med; 2008 Sep; 359(12):1291-2; author reply 1293. PubMed ID: 18799565
[No Abstract] [Full Text] [Related]
4. [Contaminated heparins].
Monneret C
Ann Pharm Fr; 2008 Aug; 66(4):212-5. PubMed ID: 18847567
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
6. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
[No Abstract] [Full Text] [Related]
7. Contaminated heparin.
Kakkar AK; Bonnefoi M
N Engl J Med; 2008 Sep; 359(12):1292-3; author reply 1293. PubMed ID: 18810795
[No Abstract] [Full Text] [Related]
8. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
[TBL] [Abstract][Full Text] [Related]
9. [Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].
Lindahl U
Lakartidningen; 2008 Sep 24-30; 105(39):2660-1. PubMed ID: 18846871
[No Abstract] [Full Text] [Related]
10. The tainted heparin story: an update.
Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
[TBL] [Abstract][Full Text] [Related]
11. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
[TBL] [Abstract][Full Text] [Related]
12. A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin.
Kalita M; Balivada S; Swarup VP; Mencio C; Raman K; Desai UR; Troyer D; Kuberan B
J Am Chem Soc; 2014 Jan; 136(2):554-7. PubMed ID: 24127748
[TBL] [Abstract][Full Text] [Related]
13. [Anaphylactoid reactions associated with contaminated heparin from China].
Montpas N; Désormeaux A; Keire D; Adam A
Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
[TBL] [Abstract][Full Text] [Related]
14. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
Bairstow S; McKee J; Nordhaus M; Johnson R
Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
[TBL] [Abstract][Full Text] [Related]
15. Contaminated heparin preparations, severe adverse events and the contact system.
Ramacciotti E; Wahi R; Messmore HL
Clin Appl Thromb Hemost; 2008 Oct; 14(4):489-91. PubMed ID: 18815138
[No Abstract] [Full Text] [Related]
16. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.
Norwig J; Beyer T; Brinz D; Holzgrabe U; Diller M; Manns D
Pharmeur Sci Notes; 2009 Mar; 2009(1):17-24. PubMed ID: 19275869
[TBL] [Abstract][Full Text] [Related]
18. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
Wielgos T; Havel K; Ivanova N; Weinberger R
J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
[TBL] [Abstract][Full Text] [Related]
19. [How safe is our treatment with heparins? (interview by Maria Weiss)].
Lindhoff-Last E
MMW Fortschr Med; 2008 May; 150(22):7. PubMed ID: 18700259
[No Abstract] [Full Text] [Related]
20. New developments in quantitative polymerase chain reaction applied to control the quality of heparins.
Auguste C; Dereux S; Martinez C; Anger P
Anal Bioanal Chem; 2011 Jan; 399(2):747-55. PubMed ID: 20931175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
